Magnus C. Halle

Magn C. Halle has been working in the biotech industry since 2016. From 2016 to 2018, they worked for NB Capital ApS as an Analyst and Personal Assistant to the CEO. In 2018, they co-founded GH Research and served as the Co-Founder and Managing Director in Ireland. At GH Research, their focus was on developing novel and proprietary 5-MeO-DMT therapies for the treatment of patients with Treatment Resistant Depression.

Magn C. Halle completed a Bachelor of Science in Economics and Business Administration (HA Almen) at Copenhagen Business School. Magnus C. also studied Economics at The London School of Economics and Political Science (LSE).